Ramakrishna Sistla

medicinal chemistry and pharmacology division

0H指数

1论文数

0被引数

收录论文 2

发表时间

Targeting PIP5K ameliorates hepatic cancer by inhibiting PI3K/AKT and the autophagy mechanism and enhancing ROS-mediated apoptosis 靶向PIP5K通过抑制PI3K/AKT和自噬机制并增强ROS介导的凋亡来改善肝癌

Frontiers in Pharmacology

IF4.8

2026-05-08

OAAI

PA P. A. Shantanu; BR Bishal Rajdev; NP N. P. Syamprasad; JK Jagadeesh Kumar Gangasani; AM Arijit Mandal; SR Samir Ranjan Panda; RS Ramakrishna Sistla; SB Sai Balaji Andugulapati; SK Shiv Kumar Sarin; DM Dinesh Mani Tripathi; VG V. G. M. Naidu

FeTMPyP a peroxynitrite decomposition catalyst ameliorated functional and behavioral deficits in chronic constriction injury induced neuropathic pain in rats

FREE RADICAL RESEARCH

IF2.9

2022-01-06

PREAI

Komirishetty, Prashanth; Areti, Aparna; Arruri, Vijay Kumar; Sistla, Ramakrishna; Gogoi, Ranadeep; Kumar, Ashutosh

研究方向